english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Covid-19 : Follow Prescrire's independent, evidence-based analysis of the pandemic

 COVID-19  Prescrire's editors are publishing an ongoing series of articles featuring independent analysis of developments related to the covid-19 pandemic. Useful and practical information, to help healthcare professionals gain a clear and balanced view.
1 November 2021

Known adverse effects of messenger RNA covid-19 vaccines
as of mid-2021

FEATURED REVIEW With several hundred million people worldwide now vaccinated with an mRNA vaccine, surveillance conducted by various pharmacovigilance teams has identified a few signals of very rare adverse effects, notably pericarditis and myocarditis.
Full review (2 pages) available for download by subscribers.
1 November 2021

In the November issue of Prescrire International: adverse effects of growth hormone and of thiazide diuretics

FREE DOWNLOAD In the "Adverse effects" section this month, Prescrire reports on the cardiovascular effects of growth hormone, and on ocular adverse effects of thiazide diuretics.
Full text available for free download.
1 November 2021

Words and numbers

 Editorial  Evidence-based medicine is more than just numbers reported in randomised trials or meta-analyses. In some cases, the best evidence is to be found in qualitative data.
1 November 2021

Asthma and COPD: don't confuse the brand name of the drug with the brand name of the inhaler

Some drugs for asthma or chronic obstructive pulmonary disease (COPD) are supplied with an inhaler device which has its own brand name. It is important to distinguish clearly between the name of the drug and the name of the inhaler.
1 November 2021

Public health: why so many private consulting firms?

In France, private consulting firms have been called upon to play a role in public health, an area in which they have hardly distinguished themselves.
1 November 2021

Medical devices that resemble medicines: some hope for improvement but continued scrutiny is needed

The new European regulation will perhaps result in some progress in relation to medical devices which resemble medicines. All will depend on how diligently it is applied.
1 November 2021

Covid-19 vaccine booster dose: great uncertainty over its value in the general population

 COVID-19  In the November edition of Prescrire International: what do the data indicate regarding the value of a booster dose for the general population? And what are the implications for the prevention of symptomatic covid-19?
1 November 2021

  The 2021 "Prescrire Prize" is awarded
  to 4 books about health and healthcare

The recipients of the 2021 "Prix Prescrire" book awards were announced in Paris on 7 October 2021. The prize is awarded to books or other works of particular interest to the general public and/or healthcare professionals.
07 October 2021

Bulevirtide (Hepcludex°) and chronic hepatitis D: no evidence of efficacy based on clinical endpoints

FEATURED REVIEW Bulevirtide (Hepcludex°) is the first antiviral drug authorised in the European Union for adults with chronic hepatitis D. In this situation, does bulevirtide reduce the incidence and severity of hepatic complications? Does it reduce HDV transmission? And what are its adverse effects?
Full review (3 pages) available for download by subscribers.
1 October 2021

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90